PredictScript™ Pharmacogenomics (PGx) products cover a broad spectrum of genetic variants across multiple therapeutic areas including CNS, Neuropsychiatry, Pain, Cardiovascular, and Metabolic. PredictGen genetic variants evaluate potential patient response to medications that mirror those measured directly in PrecisMed products across major therapeutic areas.
PGx test conducted by a simple buccal swab. The test covers gene variants across cardiovascular, gastrointestinal, neuropsychiatric, pain, anticonvulsants, and anticoagulants. Analyzes 27 genes to aid the prescribing and management of more than 130 medications. Information is displayed in a simple format for quick interpretation.
PGx test that covers gene variants for drugs used to treat neuropsychiatric disorders including depression, anxiety, mood disorders, schizophrenia, bipolar, and chronic pain. Provides information on more than 90 medications affected by 24 genes. The test offers guidance to help avoid adverse drug reactions and optimize drug therapy for each patient in the neuropsychiatry and pain specialties.